Coronary artery disease (CAD) affects over 20 million U.S. adults and causes over 350,000 deaths annually. CAD is caused by plaque buildup that narrows arteries and reduces blood flow, which could lead to heart attacks and potential heart failure. The NAPS (Nano Artertract Plaque Seeker) is a new intravenous drug designed to target plaque-causing macrophages using iron oxide nanoparticles for precise drug delivery via a magnetic field. With NAPS, CAD patients will experience fewer heart complications and live a better life.
The project website.
Explore the exceptional achievement of a Toshiba ExploraVision national winner, showcasing one of the top science fair projects in this top STEM competition. These winning teams, from K-12 students, demonstrate next-generation innovation by researching current technologies, envisioning future advancements, and presenting well-crafted project descriptions, prototypes, and dynamic web presentations. Their groundbreaking entries exemplify critical thinking, creativity, and interdisciplinary knowledge, making national recognition a powerful testament to excellence. Whether you’re a teacher, mentor, or aspiring participant, reviewing these illuminating projects offers valuable insights into what it takes to succeed in the ExploraVision science competition. Discover the national winners and get inspired!